Answers are grounded in this paper and cite their sources.
Purpose This study examined the effect of cannabidiol (CBD) on adaptive functioning in boys with autism and severe cognitive and behavioral challenges using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3). Methods Primary outcome measures for a randomized, double-blind study of purified CBD and placebo are available online (Trauner et al., 2025). We now present results of a secondary outcome measure of adaptive functioning in a longitudinal design before and after treatment with CBD or placebo. Raw scores were analyzed after noting a floor effect of standard scores. Results No significant differences in adaptive functioning, except for motor skills, were found between CBD- and placebo-treated participants after 8 weeks of treatment. When compared to its immediate pre-treatment baseline, CBD (but not placebo) was associated with improvement in raw scores for Receptive and Written communication and showed near-significant improvement in Expressive Communication and Personal Skills. When compared to its immediate pre-treatment baseline, placebo was associated with improvement in Community and worsening of Motor Skills raw scores. There was a significant difference in standard and raw scores between CBD and placebo on the Motor Skills domain, with CBD treatment showing superiority to placebo. Conclusions Although no significant between-group differences were found on most measures of adaptive functioning, within-group changes from zero to 8 weeks of treatment with CBD, but not placebo, showed improved communication skills in severely autistic boys. Future studies should account for placebo effects and severity of symptoms, include a larger sample size and individuals with a range of severity.
No takes yet. Share an insight, caveat, or question.
Oppenheim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: